$ASEP COO on sepsis and biofilm infections ASEP Medical Holdings ($ASEP $ASEP.CN) was featured on CSE TV's Newest Listed Companies video from two weeks ago.
Starting at 12:43, Dr. Bob Hancock (the founder, director, and COO of ASEP) gives an overview of ASEP, sepsis, and biofilm infections.
Current industry tests require 24 hours for results to detect and confirm Sepsis. Every hour of delayed diagnosis and treatment results in a 7.6% increase in the probability of death. This often results in organ dysfunction, leading to the death of 22-30% of patients diagnosed with sepsis.
However, ASEP tests are confirmed within 1 hour and can be used to both treat and prevent Sepsis by detecting a unique gene expression profile highly associated with Sepsis and organ failure.
While ASEP has taken a bit of a hit to the stock price recently, it is likely from investors wanting to make a quick buck, rather than a long-term holder - and the long term holders are going massively capitalize once ASEP's tests are commercialized in 2022.
https://youtu.be/xwr1rxwuWSk?t=763